Testing for malaria: Rapid diagnostic tests and PCR

In this Medmastery article, read about the most common tests used worldwide for diagnosing malaria: RDTs and PCR.
Last update2nd Aug 2022

We’ve seen that diagnosing malaria subtypes can be achieved by looking at the blood film—in fact, you should still review a smear for each patient suspected to have malaria. But in developing countries, where malaria is common, and access to microscopy may be limited, rapid diagnostic tests (RDTs) are needed.

What you need to know about rapid diagnostic tests (RDTs) for malaria

Rapid diagnostic tests allow us to screen for malaria. These tests are conducted using filter paper strips that contain three types of antibodies—anti-falciparum malaria antibodies, general anti-malaria antibodies, and anti-human antibodies.

To test for malaria place serum from a patient on one of these filter paper strips, and allow it to soak in. After about 15 minutes, look at the strip. If only the control line is visible, the patient doesn't likely have malaria. If they have something other than falciparum malaria, the anti-malaria strip will be visible, but not the anti-falciparum strip. And if the patient is infected with falciparum malaria—severe malaria—all the lines will be visible. These tests have a sensitivity and specificity of greater than 90%.

Figure 1. Rapid diagnostic tests (RDTs) are conducted using filter paper strips with anti-falciparum antibodies, general anti-malaria antibodies, and control or anti-human antibodies. Applying a patient’s serum to the strip will cause visible lines to form, a) if the patient does not have malaria, the control line will be visible, b) If the patient has non-falciparum malaria, the anti-malaria line will be visible, c) If the patient has falciparum malaria, all of the lines will be visible.

Using polymerase chain reaction (PCR) to test for malaria

Polymerase chain reaction (PCR) is the most sensitive test for malaria at more than 90% sensitivity. While microscopy can detect infected red blood cells with a parasite load of 50 parasites / µL, PCR is able to detect as few as 1 parasite / µL. But of course, it’s also the most labor-intensive, the most expensive, and takes the longest to get results. PCR is available, to a limited extent, in developing countries. But in the developed world, it’s a common way to make the diagnosis, especially in returning travelers.

PCR uses a polymerase enzyme to copy the deoxyribonucleic acid (DNA) of the malaria parasite. This process increases or amplifies, the number of DNA nucleic acids so they can be more easily picked up by laboratory tests such as protein assays. So PCR can be used to diagnose malaria from a very small blood sample volume, or a blood sample that has been dried on filter paper.

Figure 2. Polymerase chain reaction (PCR) is labor- and time-intensive, expensive, and most commonly used in developed countries to diagnose malaria in returning travelers.

That’s it for now. If you want to improve your understanding of key concepts in medicine, and improve your clinical skills, make sure to register for a free trial account, which will give you access to free videos and downloads. We’ll help you make the right decisions for yourself and your patients.

Become a great clinician with our video courses and workshops

Recommended reading

  • Ashley, EA, Phyo, AP, and Woodrow, CJ. 2018. Malaria. Lancet391: 1608­–1621. PMID: 29631781
  • Fairhurst, RM and Wellems, TE. 2014. “Malaria (Plasmodium Species)”. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, edited by Bennett, JE, Dolin, R, Blaser, MJ. 8thedition. Philadelphia: Elsevier Saunders. (Fairhurst and Wellems2014, 3070–3090)
  • Phillips, MA, Burrows, JN, Manyando, C, et al. 2017. Malaria. Nat Rev Dis Primers3: 17050. PMID: 28770814
  • World Health Organization. 2015. Guidelines for the treatment of malaria third edition. World Health Organization 
  • World Health Organization. 2019. World malaria report 2019. World Health Organization 

About the author

John F. Fisher, MD MACP FIDSA
John is a Professor of Medicine (Infectious Diseases) at the Medical College of Georgia, Augusta University, USA.
Author Profile

Become an expert

BMA Highly recommendedComenius EduMedia Siegel 2017
Highly commended by the British Medical Association
Awarded in the “digital” category of the BMA Book Awards - London 2017